Standard Shoe Sole & Mould India Ltd
Incorporated in 1973, Standard Shoe Sole and Mould Ltd deals in Leather and Organic Chemicals[1]
- Market Cap ₹ 10.0 Cr.
- Current Price ₹ 19.3
- High / Low ₹ 22.5 / 16.4
- Stock P/E
- Book Value ₹ -1.66
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 8.10%
- Promoter holding has decreased over last 3 years: -27.2%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.89 | 0.22 | 0.26 | 0.00 | 0.26 | 0.15 | 1.87 | 0.00 | 0.47 | 0.11 | 0.00 | 0.00 | 0.00 | |
| 0.90 | 0.29 | 0.41 | 0.16 | 0.44 | 0.68 | 3.51 | 0.09 | 1.42 | 0.45 | 0.66 | 0.19 | 0.13 | |
| Operating Profit | -0.01 | -0.07 | -0.15 | -0.16 | -0.18 | -0.53 | -1.64 | -0.09 | -0.95 | -0.34 | -0.66 | -0.19 | -0.13 |
| OPM % | -1.12% | -31.82% | -57.69% | -69.23% | -353.33% | -87.70% | -202.13% | -309.09% | |||||
| 0.06 | 0.04 | 0.00 | 0.00 | 0.03 | 0.00 | 0.03 | 0.00 | 2.75 | 0.03 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.05 | -0.03 | -0.15 | -0.16 | -0.15 | -0.53 | -1.65 | -0.13 | 1.60 | -0.31 | -0.66 | -0.19 | -0.13 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| 0.05 | -0.03 | -0.15 | -0.16 | -0.15 | -0.53 | -1.65 | -0.13 | 1.60 | -0.31 | -0.66 | -0.19 | -0.13 | |
| EPS in Rs | 0.10 | -0.06 | -0.29 | -0.31 | -0.29 | -1.02 | -3.18 | -0.25 | 3.09 | -0.60 | -1.27 | -0.37 | -0.26 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | % |
| TTM: | 75% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | % |
| 3 Years: | 27% |
| 1 Year: | 18% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 | 5.18 |
| Reserves | -4.02 | -3.90 | -4.02 | -3.96 | -4.11 | -4.64 | -6.29 | -6.41 | -4.82 | -5.13 | -5.79 | -5.98 | -6.04 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.37 | 0.37 | 0.00 | 0.00 | 0.24 | 0.38 | 0.46 | |
| 0.78 | 0.43 | 0.49 | 0.38 | 0.60 | 0.89 | 2.13 | 1.03 | 0.55 | 0.55 | 0.51 | 0.56 | 0.55 | |
| Total Liabilities | 1.94 | 1.71 | 1.65 | 1.60 | 1.67 | 1.43 | 1.39 | 0.17 | 0.91 | 0.60 | 0.14 | 0.14 | 0.15 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.01 | 0.04 | 0.26 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 1.94 | 1.70 | 1.61 | 1.34 | 1.65 | 1.43 | 1.39 | 0.17 | 0.91 | 0.60 | 0.14 | 0.14 | 0.15 | |
| Total Assets | 1.94 | 1.71 | 1.65 | 1.60 | 1.67 | 1.43 | 1.39 | 0.17 | 0.91 | 0.60 | 0.14 | 0.14 | 0.15 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.03 | 0.03 | -0.01 | -0.26 | 0.00 | 0.01 | 0.00 | 0.00 | 0.02 | -0.26 | -0.16 | ||
| 0.03 | -0.03 | 0.00 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.24 | 0.15 | ||
| Net Cash Flow | -0.01 | 0.00 | -0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.02 | -0.02 | -0.01 | |
| Free Cash Flow | -0.03 | 0.03 | -0.01 | -0.26 | 0.00 | 0.01 | 0.00 | 0.00 | 0.02 | -0.26 | -0.16 | |
| CFO/OP | 43% | -20% | 6% | 144% | 0% | -1% | 0% | 0% | -6% | 39% | 84% |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 631.57 | 2,488.64 | 2,147.88 | 2,218.08 | 3,163.33 | 245.94 | 419.36 | 1,360.45 | ||||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 631.57 | 2,488.64 | 2,147.88 | 2,218.08 | 3,163.33 | 245.94 | 419.36 | 1,360.45 | ||||
| Working Capital Days | 631.57 | 2,355.91 | 2,049.62 | 1,445.96 | 1,314.00 | -218.61 | 271.81 | 33.18 | ||||
| ROCE % | -2.46% | -12.30% | -13.45% | -13.10% | -65.84% | -151.22% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Number |
|
||||||||||
| Debtors Turnover Ratio Ratio |
|||||||||||
Documents
Announcements
- Closure of Trading Window 28 Mar
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Feb - Newspaper Publication of UFR for the quarter ended 31st December 2025
-
Unaudited Standalone Financial Results Along With The Limited Review Report For The Quarter And Nine Months Ended 31St December, 2025
13 Feb - Unaudited standalone results and limited review for quarter and nine months ended 31 Dec 2025 approved 13 Feb 2026.
-
Board Meeting Outcome for Unaudited Standalone Financial Results Along With The Limited Review Report For The Quarter And Nine Months Ended 31St December, 2025
13 Feb - Approved unaudited standalone financial results and limited review for quarter and nine months ended 31 Dec 2025.
-
Board Meeting Intimation for Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended 31St December 2025
9 Feb - Board meeting on 13 Feb 2026 to approve unaudited Q3/9M results for period ended 31 Dec 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1][2]
Company is in the business of footwear, leatherwear, leather articles, fashion wear, shoe components, synthetic shoes, ladies heels and moulds, and also deals in chemicals viz. dyes, acids, alkalis, etc.